Euro-Pharmacies Exemestanex 20 tabs (20 mg/tab)

Exemestane (Aromasin)

Exemestane, commonly referred to as Aromasin, is primarily recognized as an active ingredient available under various brand names. This SERM medication is predominantly utilized for treating breast cancer, but it is also popular among steroid users seeking to mitigate estrogenic side effects during their cycles, especially when using aromatizable steroids.

As a member of the anti-estrogen class, Aromatase Inhibitors, Aromasin works alongside others like Anastrozole (Arimidex). Meanwhile, Selective Estrogen Receptor Modulators such as Nolvadex (Tamoxifen) and Clomid (Clomiphene) represent another subclass of anti-estrogens, both aimed at addressing estrogen-related complications.

It’s important to recognize that SERMs and AIs differ significantly in their approach to managing estrogen control and their mechanisms of action. Typically, Aromatase Inhibitors inhibit the synthesis of estrogen by obstructing the aromatase enzyme, leading to reduced estrogen levels. This makes Aromasin a valuable asset for both curbing the progression of estrogen-dependent breast cancers and managing the side effects linked to anabolic steroids that produce estrogenic effects.

Approved by the USA FDA in 1999, Aromasin quickly gained global recognition for its efficacy in lowering estrogen levels.

Half-Life

Research indicates that the half-life of Exemestane (Aromasin) is approximately 24 to 27 hours, signifying the duration for which half of the active substance remains in the system. Thus, to fully clear the compound, expect a timeframe of about 48 to 54 hours. However, it’s critical to note that detection times may extend up to two weeks if subjected to anti-doping tests.

What is Exemestane Used For?

As outlined, Aromasin serves to reduce estrogen levels, thus mitigating numerous negative effects associated with elevated estrogen. High estrogen levels can instigate various issues, akin to excesses in other substances, leading to undesirable outcomes.

By diminishing estrogen levels, both steroid users and women experiencing hormonally positive breast cancer can achieve estrogenic protection and hinder cancer cell growth, respectively. Notably, Aromasin is classified as a suicidal aromatase inhibitor, permanently disabling the aromatase enzyme upon binding. In contrast, non-suicidal AIs like Arimidex and Letrozole risk estrogen rebound post-cessation.

Studies reveal that Aromasin can decrease estrogen levels by up to 85%, solidifying its status as a potent compound for long-term suppression compared to other AIs.

Many steroid users employ anabolic agents such as Dianabol, Nandrolones, and Testosterone, which convert to estrogen, resulting in heightened estrogen levels and associated side effects, including cardiovascular issues, gynecomastia, water retention, and hypertension. Exemestane effectively addresses these challenges through its estrogen-lowering mechanisms.

Dosage

With a half-life of approximately 25-27 hours, Exemestane should be taken daily to maintain stable blood levels. Some individuals may opt for every-other-day administration to avoid excessive estrogen suppression when not necessitated. Dosage is highly individualized based on various factors, including reaction to estrogenic side effects and type and dosage of steroids employed.

Dosages typically range from 12.5 mg every other day to 25 mg daily, but excessive use can lead to detrimental estrogen suppression, resulting in other side effects.

Side Effects

Usage of high doses of Aromasin (Exemestane) may precipitate low estrogen levels, which can have adverse effects. Side effects may include:

• depression
• insomnia and low libido
• impotence
• low energy
• other potential side effects

It is crucial to avoid abusing Exemestane and to use the minimal effective dose.

Generally, side effects of Aromasin are infrequent when utilized within the normal dosing range for estrogenic protection. Most side effects are encountered in women requiring prolonged administration of this compound.

Typically, bodybuilders and steroid users require lower doses for shorter durations, minimizing side effects. Nevertheless, Exemestane is not without risks; potential side effects may include sweating, insomnia, headaches, hot flashes, and joint discomfort. Reducing the dosage often alleviates or avoids these side effects entirely.

Ultimately, the absence of any aromatase inhibitor during the use of aromatizable steroids increases the likelihood of experiencing adverse effects compared to implementing any form of estrogenic protection.